Effective, single-dose treatment of porcine cysticercosis with oxfendazole

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 4, 1996, Pages 391-394

  Gonzales, Armando E ^a   Garcia, Hector H ^b   Gilman, Robert H ^c   Gavidia, Cesar M ^a   Tsang, Victor C W ^d   Bernal, Teresa ^a   Falcon, Nestor ^a   Romero, Martha ^a   Lopez Urbina, Maria T ^a  

^a UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXFENDAZOLE; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYSTICERCOSIS; NONHUMAN; PARASITE CONTROL; PARASITE TRANSMISSION; SWINE DISEASE; TAENIA SOLIUM; TAENIASIS;

EID: 0029915372     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.391     Document Type: Article

References (23)

1. Garcia HH, Martinez M, Gilman RH, Herrera G, Tsang VCW, Pilcher JB, Diaz F, Verastegui M, Gallo C, Porras M, Alvarado M, Naranjo J, Miranda E, and The Cysticercosis Working Group in Peru, 1991. Diagnosis of cysticercosis in endemic regions. Lancet 338: 549-551.
2. Flisser A, 1988. Neurocysticercosis in Mexico. Parasitol Today 4: 131-136.
3. Cysticercosis Working Group in Peru, 1993. The marketing of cysticercotic pigs in the sierra of Peru. Bull World Health Organ 71: 223-228.
4. Acha P, Szyfres B, 1986. Zoonosis y Enfermedades Transmisibles Comunes al Hombre y Los Animales. Second edition. Washington, DC: Pan American Health Organization, 763-774.
5. Gonzalez AE, Cama V, Gilman RH, Tsang VCW, Pilcher JB, Chavera A, Castro M, Montenegro T, Verastegui M, Miranda E, Bazalar H, 1990. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg 43: 194-199.
6. Matias R, Pawlovsky SZ, Soulby ESL, 1983. Guidelines for Surveillance Prevention and Control of Taeniasis and Cysticercosis. VPH doc. 8349. Geneva: World Health Organization.
7. Cruz M, Davis A, Dixon H, Pawlowski ZS, Proano J, 1989. Operational studies on the control of Taenia solium taeniasis/ cysticercosis in Ecuador. Bull World Health Organ 67: 401-407.
8. Schantz PM, Cruz M, Sarti E, Pawlowski Z, 1993. Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ 27: 397-403.
9. Tellez-Giron E, Ramos MC, Montante M, 1981. Effect of flubendazole on Cysticercus cellulosae in pigs. Am J Trop Med Hyg 30: 135-138.
10. Flisser A, Gonzalez D, Shkurovich M, Madrazo I, Correa D, Rodriguez-Carbajal J, Cohen S, Rodriguez-del-Rosal E, Collado M, Fernandez B, Fernandez F, De Aluja AS, 1990. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies. Parasitol Res 76: 263-269.
11. Torres A, Plancarte A, Villalobos ANM, De Aluja AS, Navarro R, Flisser A, 1992. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment. Parasitol Res 78: 161-164.
12. Gonzales AE, Garcia HH, Gilman RH, Lopez MT, Gavidia C, McDonald J, Pilcher JB, Tsang VCW, 1995. Treatment of porcine cysticercosis with albendazole. Am J Trop Med Hyg 53: 571-574.
13. Marriner SE, Bogan JA, 1981. Pharmacokinetics of oxfendazole in sheep. Am J Vet Res 42: 1143-1145.
14. Straw BE, Meuten DJ, 1992. Physical examination. Leman AD, Straw BE, Mengeling WL, D'Allaire S, Taylor DJ, eds. Diseases of Swine, Seventh edition. Ames, IA: Iowa State University Press, 793-807.
15. Canedo L, Laclette JP, Morales E, 1982. Evagination of the metacestode of Taenia solium. Flisser A, Williams K, Laclette JP, Larralde C, Ridaura C, Beltran F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York: Academic Press, 363-374.
16. Nash TE, Neva FA, 1984. Recent advances in the diagnosis and treatment of cerebral cysticercosis. N Engl J Med 311: 1492-1496.
17. Del Brutto OH, Sotelo J, 1988. Neurocysticercosis: an update. Rev Infect Dis 10: 1075-1087.
18. Diaz F, Garcia HH, Gilman R, Gonzales E, Castro M, Tsang VCW, Pilcher JB, Vasquez L, Lescano M, Carcamo C, Madico G, Miranda E, and The Cysticercosis Working Group in Peru, 1992. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol 135: 875-882.
19. Garcia HH, Gilman R, Martinez M, Tsang VCW, Pilcher JB, Herrera G, Diaz F, Torres M, Alvarado M, Orrillo E, Torres P, Miranda E, and The Cysticercosis Working Group in Peru (CWG), 1993. Cysticercosis as a major cause of epilepsy in Peru. Lancet 341: 197-200.
20. Garcia HH, Herrera G, Gilman RH, Tsang VCW, Pilcher JB, Diaz JF, Candy EJ, Miranda E, Nararjo J, and The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board), 1994. Discrepancies between cerebral computed tomography and Western blot in the diagnosis of neurocysticercosis. Am J Trop Med Hyg 50: 152-157.
21. Garcia HH, Gilman RH, Tovar MA, Flores E, Jo R, Tsang VCW, Diaz F, Torres P, Miranda E, and The Cysticercosis Working Group in Peru (CWG), 1995. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Am J Trop Med Hyg 52: 145-148.
22. Del Brutto OH, Sotelo J, Roman GC, 1993. Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 17: 730-735.
23. Bolero D, Uribe CS, Sanchez JL, Alzale T, Velasquez G, Ocampo NE, Villa LA, 1993. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 87: 576-577.